chr12-57747761-GAC-G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_000075.4(CDK4):c.*762_*763delGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000974 in 143,782 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000097 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CDK4
NM_000075.4 3_prime_UTR
NM_000075.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0620
Publications
1 publications found
Genes affected
CDK4 (HGNC:1773): (cyclin dependent kinase 4) The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]
TSPAN31 (HGNC:10539): (tetraspanin 31) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is thought to be involved in growth-related cellular processes. This gene is associated with tumorigenesis and osteosarcoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK4 | NM_000075.4 | c.*762_*763delGT | 3_prime_UTR_variant | Exon 8 of 8 | ENST00000257904.11 | NP_000066.1 | ||
TSPAN31 | NM_005981.5 | c.*475_*476delCA | 3_prime_UTR_variant | Exon 6 of 6 | ENST00000257910.8 | NP_005972.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK4 | ENST00000257904.11 | c.*762_*763delGT | 3_prime_UTR_variant | Exon 8 of 8 | 1 | NM_000075.4 | ENSP00000257904.5 | |||
TSPAN31 | ENST00000257910.8 | c.*475_*476delCA | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_005981.5 | ENSP00000257910.3 |
Frequencies
GnomAD3 genomes AF: 0.0000974 AC: 14AN: 143782Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14
AN:
143782
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 7346Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 3590
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
7346
Hom.:
AF XY:
AC XY:
0
AN XY:
3590
African (AFR)
AF:
AC:
0
AN:
118
American (AMR)
AF:
AC:
0
AN:
624
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
334
East Asian (EAS)
AF:
AC:
0
AN:
930
South Asian (SAS)
AF:
AC:
0
AN:
362
European-Finnish (FIN)
AF:
AC:
0
AN:
30
Middle Eastern (MID)
AF:
AC:
0
AN:
20
European-Non Finnish (NFE)
AF:
AC:
0
AN:
4500
Other (OTH)
AF:
AC:
0
AN:
428
GnomAD4 genome AF: 0.0000974 AC: 14AN: 143782Hom.: 0 Cov.: 32 AF XY: 0.000129 AC XY: 9AN XY: 69666 show subpopulations
GnomAD4 genome
AF:
AC:
14
AN:
143782
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
69666
show subpopulations
African (AFR)
AF:
AC:
5
AN:
38880
American (AMR)
AF:
AC:
0
AN:
14514
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3376
East Asian (EAS)
AF:
AC:
0
AN:
4936
South Asian (SAS)
AF:
AC:
0
AN:
4570
European-Finnish (FIN)
AF:
AC:
0
AN:
8812
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
9
AN:
65522
Other (OTH)
AF:
AC:
0
AN:
1980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Cutaneous Malignant Melanoma, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.